Log in to save to my catalogue

β-Catenin signaling in hepatocellular carcinoma

β-Catenin signaling in hepatocellular carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac9a697243b64e79b57cc27e96df1568

β-Catenin signaling in hepatocellular carcinoma

About this item

Full title

β-Catenin signaling in hepatocellular carcinoma

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2022-02, Vol.132 (4), p.1-10

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Deregulated Wnt/β-catenin signaling is one of the main genetic alterations in human hepatocellular carcinoma (HCC). Comprehensive genomic analyses have revealed that gain-of-function mutation of CTNNB1, which encodes β-catenin, and loss-of-function mutation of AXIN1 occur in approximately 35% of human HCC samples. Human HCCs with activation of the...

Alternative Titles

Full title

β-Catenin signaling in hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ac9a697243b64e79b57cc27e96df1568

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac9a697243b64e79b57cc27e96df1568

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI154515

How to access this item